Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ad26.COV2.S Booster in Kidney Transplant Recipients
NCT05220397Phase 3Terminated
- Start
- Apr 2022
- Primary completion
- Feb 2025
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Ad26.COV2.S in coronavirus disease 2019 (COVID-19). Started Apr 2022; status: terminated.
02
Drugs
Ad26.COV2.S
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05220397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05220397.